tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Ownership - Who Owns Immunome?

244 Followers

Immunome (IMNM) Ownership Overview

1.73%22.97%39.22%10.63%25.44%
39.22% Other Institutional Investors
10.63% ETFs
25.44% Public Companies and Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 72.83% of the company’s stock is owned by Institutional Investors, 1.73% is owned by Insiders, and 25.44% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 62.19% of the company’s stock is owned by Institutional Investors, 1.73% is owned by Insiders, and 10.63% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 25, 2024
xxxxxxxxxxxxx
$149673
Nov 25, 2024
xxxxxxxxxxxxx
$198030
Nov 25, 2024
Clay Siegall
President & Ceo,director
xxxxxxxxxxxxx
$961807
Sep 20, 2024
xxxxxxxxxxxxx
$230224

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$4105296
Sep 30, 2024
xxxxxxxxxxxxx
$13514611

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,729,342Institution4.37%27,593,648
2,470,503Institution3.96%24,976,785
2,254,951Institution3.61%22,797,555
2,069,087Institution3.31%20,918,470
2,041,991Institution3.27%20,644,529
1,526,696Institution2.45%15,434,897
1,026,667Institution1.64%10,379,603
1,012,962Institution1.62%10,241,046
924,392Institution1.48%9,345,603
799,549Institution1.28%8,083,440

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,470,503Institution3.96%24,976,785
2,069,087Institution3.31%20,918,470
2,041,991Institution3.27%20,644,529
1,526,696Institution2.45%15,434,897
1,026,667Institution1.64%10,379,603
799,549Institution1.28%8,083,440
744,815Institution1.19%7,530,080
560,744Institution0.90%5,669,122
448,244Institution0.72%4,531,747
394,182Institution0.63%3,985,180

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,463,496Institution2.34%19,830,371
1,385,946Institution2.22%14,011,914
907,746Institution1.45%8,514,657
834,659Institution1.34%11,309,629
473,679Institution0.76%4,788,895
272,209Institution0.44%2,553,320
243,467Institution0.39%3,298,978
128,451Institution0.21%1,740,511
119,347Institution0.19%1,206,598
92,613Institution0.15%868,710

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 39.22% of the company's stock is held by institutional investors, 1.73% is held by insiders, and 25.44% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 39.22% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 25.44% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        Vanguard owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis